sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 25, 2026

This 10.5% Dividend Shines as Americans Get Richer (and Are Less Happy About It)

View original at nasdaq.com
This 10.5% Dividend Shines as Americans Get Richer (and Are Less Happy About It) There's a clear "disconnect" happening in the US economy right now…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The AI buildout is benefiting utilities, energy, infrastructure, construction, transport, retail and other industries, appearing in US companies' bottom lines including riskier firms

    60% confidence
  • Inflation-adjusted worker earnings were flat from 1980 to 2015, then began growing in the late 2010s and have continued to rise, even as consumer sentiment has declined

    60% confidence
  • The S&P 500 averages approximately 10% per year including dividends historically

    60% confidence
  • All past major market selloffs including Liberation Day tariffs, the Iran conflict, and the 2022 inflation selloff were buying opportunities, and future pullbacks will be too

    60% confidence
  • CEFs offer access to holdings at a discount to NAV, a deal that does not exist with ETFs

    60% confidence
  • The 60-Paycheck Dividend Plan consists of 5 hand-picked monthly-paying CEFs yielding 9.3% in aggregate, delivering 60 dividend checks per year

    60% confidence
  • USA currently trades at an 11.3% discount to NAV, well below its 7.5% one-year average and far below its 0.7% five-year average

    60% confidence
  • USA generates its 10.5% dividend by linking the payout to NAV and committing to distributing approximately 10% of NAV annually; the quarterly payout floats slightly

    60% confidence
  • American families are less likely to default on debts than in the 2010s and there has been a sharp drop in defaults since early 2025, potentially due to AI-related job opportunities

    60% confidence
  • Default rates in the speculative credit market are falling significantly, most rapidly in the loan market that drove the private-credit panic

    60% confidence
  • S&P 500 firms booked year-over-year earnings gains north of 11% in Q1, the highest since 2022, with sales growth accelerating for years partly due to AI

    60% confidence
  • USA has delivered a 12.3% annualized total return over the last decade consistently

    60% confidence
  • S&P 500 company sales growth has been accelerating for years, in part due to businesses benefiting from the AI boom

    60% confidence
  • Americans are generally getting richer while sentiment is declining simultaneously, creating a paradoxical disconnect

    60% confidence
  • The S&P 500 returned 25% in the last year

    60% confidence
  • Liberty All-Star Equity Fund (USA) is a 10.5%-yielding closed-end fund holding large-cap S&P 500 stocks

    60% confidence
  • Current University of Michigan consumer sentiment is at its lowest level in approximately 50 years

    60% confidence

Data points we hold from this source

S&P 500 Index Fund · historical avg annual return10 percent
S&P 500 Index Fund · trailing 1yr return25 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
This 10.5% Dividend Shines as Americans Get Richer (and Are Less Happy About It) — Source | Via News | pt.VIA.NEWS